Skip to main content
. Author manuscript; available in PMC: 2020 Mar 7.
Published in final edited form as: Nanoscale. 2019 Mar 7;11(10):4531–4545. doi: 10.1039/C8NR07667G

Figure 5.

Figure 5

Cell viability of HepG2 cells exposed to different concentrations (10, 50, 100 μg/mL) of MSNs, MSNs-BSA, MSNs-Tf, MSNs-BSA-AgNPs and MSNs-Tf-AgNPs for 24 (A), 48 (B) and 72 (C) hours (n=5). Data were analyzed by ANOVA followed by Bonferroni´s multiple-comparison test. ***p < 0.001 versus MSNs-Tf. #p < 0.05. ##p < 0.01 ###p < 0.001 versus MSNs-BSA-AgNPs.